NewsRoom Articles - Page 185 of 221

WednesdayJan 27, 2021 3:46 pm

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Discusses Product Pipeline, Clinical Trial Plans, at H.C. Wainwright Bioconnect 2021 Virtual Conference

Company will initiate a Phase II adult trial for Berubicin this year focused on patients with glioblastoma multiforme WPD, a CNS sub-license partner, will be commencing a parallel Phase II adult trial and the first-ever pediatric Berubicin trial Additional clinical trials are in the pipeline, including one for the company’s newest drug candidate, WP1244, and its effects on central nervous system tumors Biopharmaceutical company CNS Pharmaceuticals (NASDAQ: CNSP) recently took part in the H.C. Wainwright Bioconnect 2021 Virtual Conference, which took place January 11-14, 2021. CNS’s CEO John Climaco gave a presentation at the event, discussing how the clinical-stage biopharmaceutical…

WednesdayJan 27, 2021 3:00 pm

New Study Discovers Patient’s Immune System Continues Building Resistance After Recovering from COVID-19

The novel coronavirus has affected many countries, infecting roughly 96.2 million people across the globe. Of the 96 million individuals, about 53 million have recovered from this disease while nearly 2 million individuals have, sadly, succumbed to the deadly infection. Researchers have been trying to figure out how long the immunity of an individual who recovered from the disease will last. A recent study by Rockefeller University researchers provides an answer to this, suggesting that individuals who recover from the coronavirus are protected against the deadly infection for about six months, and likely much longer. The study’s findings provide strong…

TuesdayJan 26, 2021 2:46 pm

MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) Well Placed as Agricultural Biopesticides Market Expected to Grow Rapidly

Research shows that market for agricultural biopesticides expected to grow rapidly at CAGR of 14.7% until 2025 MustGrow providing natural plant-based biopesticide solutions for protecting plants from pests and diseases, utilizing the natural defense mechanism of the mustard plant Company seems well positioned within biopesticides market expected to achieve fastest growth The market for agricultural biopesticides is growing rapidly. The latest Markets and Markets report estimated the industry was valued at $4.3 billion in 2020 and is projected to almost double its size in the next five years — reaching $8.5 billion by 2025 and growing at a CAGR of…

TuesdayJan 26, 2021 2:30 pm

Study Reveals Connection Between Mental Health Issues and Obesity in Adolescents

A new study by scientists from the University of Gothenburg in Sweden and Lund University, has discovered that many young people who are treated for severe obesity also possess neuropsychiatric issues. More than half of the teens from the study suffered from various mental health conditions, as reported by their parents or themselves. While the link between eating disorders, depression and ADHD has long been observed by researchers, not a lot of research that has been focused on the connection. However, the research that is available has shown that from the early 2000s, both mental illness and obesity have increased…

TuesdayJan 26, 2021 2:12 pm

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Enters 2021 with Optimism for Its Cancer Imaging Technology

Imagin Medical Inc. successfully weathered the 2020 pandemic-induced economic challenges and transitioned its surgical visualization product, the i/Blue Imaging System(TM) from the development stage to manufacturing and has after Imagin’s next stage will be supported by a $3 million convertible note, with the final funding tranche expected to close this quarter The i/Blue Imaging System combines the advantages of blue light with advanced optic and light sensors to address the limitations of both white and blue light imaging to help surgeons better visualize and remove cancerous cells. The system uses a contrast agent to highlight the cancer and projects both…

MondayJan 25, 2021 1:14 pm

United Medical Equipment Business Solutions Network Inc. Adds CareStart Antigen Test to List of COVID-19 Supplies

UME commited to offering high-quality COVID-19 services, solutions and supplies. To effectively end worldwide pandemic, systematic screening and detection of both clinical and asumptomatic COVID-19 tests is critical. CareStart antigen test features 10-minute processing time, identifies acute infection, helps provide critical answers. Despite approval and rollout of COVID-19 vaccines, experts agree that even as the pandemic dies down in the coming months, SARS-CoV-2, the virus that causes the infectious disease, is likely here for the long haul (https://ibn.fm/1idh8). United Medical Equipment Business Solutions Network ("UME") is here for the long haul too, commited to offering high-quality COVID-19 services, solutions and supplies.…

FridayJan 22, 2021 2:30 pm

Artificial Intelligence Could Improve IVF Outcomes

A study conducted in 2017 forecasted that artificial intelligence (AI) could extensively improve health-care results by 30–40%. AiVF, an Israeli ML company, has suggested that artificial intelligence bears the potential to grow the success rate of IVF by almost three times when compared to conventional methods. It should be noted, however, that pregnancy is dependent on other factors, such as age. IVF, or in vitro-fertilization, is a series of procedures that involves the extraction of mature ova from a woman’s body, which are then fertilized in a lab setting with sperm in a liquid. The fertilized ovum is then implanted…

FridayJan 22, 2021 2:28 pm

MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) Disrupting Global Agricultural Markets

Company shares update of biopesticide product pipeline MGROF committed to combating deadly crop diseases, pests in Colombia and North America MustGrow touts potential additional uses as bioherbicide, sprout suppressor MustGrow Biologics (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0), an agriculture biotech company focused on providing natural science-based biological solutions for high-value crops and other markets, recently provided an update of its biopesticide product pipeline (https://ibn.fm/eOTGT). By extracting natural compounds from within the mustard seed — the mustard plant’s natural defense mechanism — the company has provided natural solutions to potentially replace widely used harmful synthetics that are being banned and deregistered. As…

ThursdayJan 21, 2021 12:45 pm

Tired of Dairy? Tel Aviv Researchers May Have Just What You Need, Milk From Yeast!

A researcher from Tel Aviv University has developed a way to produce dairy products from yeast. Professor Tamir Tuller from the university’s Department of Biomedical Engineering is the researcher behind this innovative development. Tuller worked together with Dr. Eyal Iffergan, a food technology entrepreneur, to set up Imagindairy, a start-up company that plans to make cow’s milk using yeast. This development comes at a time when researchers are working on finding substitutes for milk because dairy farming damages not only the environment but also human health. Tuller explained that Imagindairy’s objective was to create milk that contained all the nutritional…

WednesdayJan 20, 2021 1:30 pm

Magnetic Nanoparticles May Be Used to Improve Cancer Treatment in the Near Future

A team of researchers from the University College London has demonstrated how small magnetic nanoparticles can be used to improve cancer treatment. Those nanoparticles can transport chemo drugs to cancer cells while also generating a minimal heating effect once stimulated through the use of an alternating external magnetic field. The combination of chemotherapy and particle-mediated heat treatment brings about synergistic effects in the elimination of cancer cells. This proposes that the technology may be a useful tool in the fight against cancer. The nanoparticles are made from iron oxide, which make them magnetic. These particles can be stimulated to generate…

News and publishing service for medical and biotechnology related companies

Contact us: 512.354.7000

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Discusses Product Pipeline, Clinical Trial Plans, at H.C. Wainwright Bioconnect 2021 Virtual Conference

New Study Discovers Patient’s Immune System Continues Building Resistance After Recovering from COVID-19

MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) Well Placed as Agricultural Biopesticides Market Expected to Grow Rapidly

Study Reveals Connection Between Mental Health Issues and Obesity in Adolescents

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Enters 2021 with Optimism for Its Cancer Imaging Technology

United Medical Equipment Business Solutions Network Inc. Adds CareStart Antigen Test to List of COVID-19 Supplies

Artificial Intelligence Could Improve IVF Outcomes

MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) Disrupting Global Agricultural Markets

Tired of Dairy? Tel Aviv Researchers May Have Just What You Need, Milk From Yeast!

Magnetic Nanoparticles May Be Used to Improve Cancer Treatment in the Near Future

Official NewsWire Relationships

BioMedWire Currently Accepts

BioMedWire

Company Search

Site Search